摘要 |
Compounds of the formula (I), in which R<SUP>1a</SUP>-R<SUP>1c</SUP>, R<SUP>2a</SUP>, R<SUP>2b</SUP>, R<SUP>3 </SUP>and R<SUP>5 </SUP>have the meanings indicated in claim 1 , are inhibitors of tyrosine kinases, in particular TIE-2, and Raf kinases and can be employed, inter alia, for the treatment of tumours.
|